nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—Vismodegib—Sorafenib—thyroid cancer	0.438	1	CrCrCtD
Sulfasalazine—PPARG—thyroid cancer	0.226	0.703	CbGaD
Sulfasalazine—PTGS2—thyroid cancer	0.0955	0.297	CbGaD
Sulfasalazine—ABCG2—Vandetanib—thyroid cancer	0.0429	0.296	CbGbCtD
Sulfasalazine—ABCC2—Sorafenib—thyroid cancer	0.0286	0.198	CbGbCtD
Sulfasalazine—ABCG2—Sorafenib—thyroid cancer	0.0259	0.179	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—thyroid cancer	0.0174	0.12	CbGbCtD
Sulfasalazine—ABCG2—Doxorubicin—thyroid cancer	0.0157	0.108	CbGbCtD
Sulfasalazine—CYP3A5—Sorafenib—thyroid cancer	0.0143	0.099	CbGbCtD
Sulfasalazine—ACAT1—thyroid gland—thyroid cancer	0.00129	0.0632	CbGeAlD
Sulfasalazine—ACAT1—head—thyroid cancer	0.00115	0.0561	CbGeAlD
Sulfasalazine—TBXAS1—thyroid gland—thyroid cancer	0.00108	0.0529	CbGeAlD
Sulfasalazine—CHUK—thyroid gland—thyroid cancer	0.000964	0.0471	CbGeAlD
Sulfasalazine—SLC46A1—thyroid gland—thyroid cancer	0.000964	0.0471	CbGeAlD
Sulfasalazine—TBXAS1—head—thyroid cancer	0.00096	0.0469	CbGeAlD
Sulfasalazine—Balsalazide—PPARG—thyroid cancer	0.000929	0.38	CrCbGaD
Sulfasalazine—PPARG—neck—thyroid cancer	0.000857	0.0419	CbGeAlD
Sulfasalazine—CHUK—head—thyroid cancer	0.000856	0.0418	CbGeAlD
Sulfasalazine—SLC46A1—head—thyroid cancer	0.000856	0.0418	CbGeAlD
Sulfasalazine—PLA2G1B—head—thyroid cancer	0.000804	0.0393	CbGeAlD
Sulfasalazine—ACAT1—lymph node—thyroid cancer	0.000804	0.0393	CbGeAlD
Sulfasalazine—SLC7A11—thyroid gland—thyroid cancer	0.000794	0.0388	CbGeAlD
Sulfasalazine—Olsalazine—PPARG—thyroid cancer	0.00079	0.323	CrCbGaD
Sulfasalazine—SLC7A11—head—thyroid cancer	0.000705	0.0344	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—thyroid cancer	0.000672	0.0328	CbGeAlD
Sulfasalazine—IKBKB—thyroid gland—thyroid cancer	0.000656	0.032	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—thyroid cancer	0.000599	0.0293	CbGeAlD
Sulfasalazine—CHUK—lymph node—thyroid cancer	0.000599	0.0293	CbGeAlD
Sulfasalazine—IKBKB—head—thyroid cancer	0.000582	0.0284	CbGeAlD
Sulfasalazine—ALOX5—thyroid gland—thyroid cancer	0.000543	0.0265	CbGeAlD
Sulfasalazine—ALOX5—head—thyroid cancer	0.000482	0.0236	CbGeAlD
Sulfasalazine—ABCG2—saliva-secreting gland—thyroid cancer	0.000429	0.0209	CbGeAlD
Sulfasalazine—PPARG—thyroid gland—thyroid cancer	0.000408	0.0199	CbGeAlD
Sulfasalazine—IKBKB—lymph node—thyroid cancer	0.000407	0.0199	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—thyroid cancer	0.000392	0.16	CrCbGaD
Sulfasalazine—PPARG—head—thyroid cancer	0.000362	0.0177	CbGeAlD
Sulfasalazine—ALOX5—lymph node—thyroid cancer	0.000338	0.0165	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—thyroid cancer	0.000334	0.136	CrCbGaD
Sulfasalazine—PTGS1—trachea—thyroid cancer	0.000276	0.0135	CbGeAlD
Sulfasalazine—PTGS2—trachea—thyroid cancer	0.000264	0.0129	CbGeAlD
Sulfasalazine—ABCG2—thyroid gland—thyroid cancer	0.000261	0.0128	CbGeAlD
Sulfasalazine—PPARG—lymph node—thyroid cancer	0.000253	0.0124	CbGeAlD
Sulfasalazine—ABCC2—lymph node—thyroid cancer	0.000223	0.0109	CbGeAlD
Sulfasalazine—PTGS1—thyroid gland—thyroid cancer	0.000218	0.0107	CbGeAlD
Sulfasalazine—PTGS1—head—thyroid cancer	0.000193	0.00945	CbGeAlD
Sulfasalazine—PTGS2—head—thyroid cancer	0.000185	0.00904	CbGeAlD
Sulfasalazine—ABCG2—lymph node—thyroid cancer	0.000162	0.00794	CbGeAlD
Sulfasalazine—PTGS1—lymph node—thyroid cancer	0.000135	0.00662	CbGeAlD
Sulfasalazine—PTGS2—lymph node—thyroid cancer	0.000129	0.00633	CbGeAlD
Sulfasalazine—IKBKB—Adaptive Immune System—NRG1—thyroid cancer	1.76e-05	0.000242	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PRKAR1A—thyroid cancer	1.75e-05	0.000241	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.75e-05	0.00024	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTGS2—thyroid cancer	1.74e-05	0.00024	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TCF7L1—thyroid cancer	1.73e-05	0.000239	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—HPGD—thyroid cancer	1.73e-05	0.000238	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling of activated FGFR—AKT1—thyroid cancer	1.72e-05	0.000237	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—thyroid cancer	1.71e-05	0.000236	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—AKT1—thyroid cancer	1.71e-05	0.000235	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HRAS—thyroid cancer	1.7e-05	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	1.7e-05	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—HRAS—thyroid cancer	1.7e-05	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB4—AKT1—thyroid cancer	1.7e-05	0.000234	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—HRAS—thyroid cancer	1.69e-05	0.000232	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—thyroid cancer	1.68e-05	0.000232	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—KRAS—thyroid cancer	1.68e-05	0.000231	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	1.67e-05	0.00023	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—HRAS—thyroid cancer	1.67e-05	0.00023	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—HRAS—thyroid cancer	1.67e-05	0.00023	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—HRAS—thyroid cancer	1.66e-05	0.000229	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—AKT1—thyroid cancer	1.65e-05	0.000227	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—thyroid cancer	1.65e-05	0.000227	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—HPGD—thyroid cancer	1.62e-05	0.000223	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signal transduction—AKT1—thyroid cancer	1.62e-05	0.000223	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TCF7L1—thyroid cancer	1.62e-05	0.000223	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—HRAS—thyroid cancer	1.62e-05	0.000222	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PPARG—thyroid cancer	1.61e-05	0.000222	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR—AKT1—thyroid cancer	1.61e-05	0.000222	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—NRAS—thyroid cancer	1.61e-05	0.000222	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—PTEN—thyroid cancer	1.61e-05	0.000222	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—AKT1—thyroid cancer	1.61e-05	0.000221	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by ERBB2—AKT1—thyroid cancer	1.6e-05	0.000221	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 signaling—AKT1—thyroid cancer	1.6e-05	0.00022	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—NRAS—thyroid cancer	1.58e-05	0.000218	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PTEN—thyroid cancer	1.58e-05	0.000218	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—HRAS—thyroid cancer	1.57e-05	0.000217	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—HRAS—thyroid cancer	1.57e-05	0.000217	CbGpPWpGaD
Sulfasalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	1.57e-05	0.000217	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—HRAS—thyroid cancer	1.54e-05	0.000212	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTGS2—thyroid cancer	1.52e-05	0.000209	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTEN—thyroid cancer	1.52e-05	0.000209	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—HRAS—thyroid cancer	1.51e-05	0.000207	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.5e-05	0.000207	CbGpPWpGaD
Sulfasalazine—CHUK—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	1.5e-05	0.000207	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—AKT1—thyroid cancer	1.5e-05	0.000207	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by FGFR in disease—AKT1—thyroid cancer	1.5e-05	0.000207	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CALCA—thyroid cancer	1.5e-05	0.000206	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR—AKT1—thyroid cancer	1.49e-05	0.000205	CbGpPWpGaD
Sulfasalazine—IKBKB—Insulin Signaling—AKT1—thyroid cancer	1.48e-05	0.000203	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by EGFR in Cancer—AKT1—thyroid cancer	1.48e-05	0.000203	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by PDGF—AKT1—thyroid cancer	1.47e-05	0.000202	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDK1—thyroid cancer	1.47e-05	0.000202	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—NRAS—thyroid cancer	1.46e-05	0.000201	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—thyroid cancer	1.46e-05	0.000201	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.45e-05	0.0002	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—RXRA—thyroid cancer	1.44e-05	0.000199	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—NRAS—thyroid cancer	1.44e-05	0.000198	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—HRAS—thyroid cancer	1.43e-05	0.000197	CbGpPWpGaD
Sulfasalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thyroid cancer	1.43e-05	0.000196	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—AKT1—thyroid cancer	1.42e-05	0.000195	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	1.41e-05	0.000195	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—NRAS—thyroid cancer	1.41e-05	0.000195	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IFNA2—thyroid cancer	1.41e-05	0.000194	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TPR—thyroid cancer	1.4e-05	0.000193	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	1.4e-05	0.000193	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TSHR—thyroid cancer	1.4e-05	0.000193	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—AKT1—thyroid cancer	1.39e-05	0.000191	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—AKT1—thyroid cancer	1.39e-05	0.000191	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—KRAS—thyroid cancer	1.39e-05	0.000191	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	1.38e-05	0.00019	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PRKAR1A—thyroid cancer	1.38e-05	0.00019	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—KRAS—thyroid cancer	1.36e-05	0.000188	CbGpPWpGaD
Sulfasalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—AKT1—thyroid cancer	1.36e-05	0.000188	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDK1—thyroid cancer	1.35e-05	0.000186	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—SLC5A5—thyroid cancer	1.33e-05	0.000184	CbGpPWpGaD
Sulfasalazine—CHUK—NGF signalling via TRKA from the plasma membrane—AKT1—thyroid cancer	1.33e-05	0.000183	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDK1—thyroid cancer	1.33e-05	0.000183	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTEN—thyroid cancer	1.33e-05	0.000183	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MEN1—thyroid cancer	1.32e-05	0.000181	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TPR—thyroid cancer	1.3e-05	0.000179	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IFNA2—thyroid cancer	1.28e-05	0.000176	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.28e-05	0.000176	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTGS2—thyroid cancer	1.27e-05	0.000175	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TSHR—thyroid cancer	1.27e-05	0.000175	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—AKT1—thyroid cancer	1.26e-05	0.000174	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—KRAS—thyroid cancer	1.26e-05	0.000173	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.25e-05	0.000172	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.25e-05	0.000172	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TPR—thyroid cancer	1.25e-05	0.000172	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PRKAR1A—thyroid cancer	1.25e-05	0.000172	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—KRAS—thyroid cancer	1.24e-05	0.00017	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PRKAR1A—thyroid cancer	1.23e-05	0.000169	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—KRAS—thyroid cancer	1.22e-05	0.000167	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MEN1—thyroid cancer	1.19e-05	0.000164	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTCH1—thyroid cancer	1.19e-05	0.000164	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TPR—thyroid cancer	1.18e-05	0.000163	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HRAS—thyroid cancer	1.18e-05	0.000162	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NRG1—thyroid cancer	1.18e-05	0.000162	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PRKAR1A—thyroid cancer	1.16e-05	0.00016	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—HRAS—thyroid cancer	1.16e-05	0.00016	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—AKT1—thyroid cancer	1.15e-05	0.000159	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PPARG—thyroid cancer	1.14e-05	0.000157	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—RXRA—thyroid cancer	1.12e-05	0.000154	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	1.12e-05	0.000154	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.11e-05	0.000153	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MEN1—thyroid cancer	1.11e-05	0.000153	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTEN—thyroid cancer	1.11e-05	0.000152	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.09e-05	0.00015	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—NRAS—thyroid cancer	1.09e-05	0.00015	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SST—thyroid cancer	1.09e-05	0.00015	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NRG1—thyroid cancer	1.09e-05	0.00015	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTCH1—thyroid cancer	1.08e-05	0.000149	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HRAS—thyroid cancer	1.07e-05	0.000147	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NRG1—thyroid cancer	1.07e-05	0.000147	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	1.05e-05	0.000145	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—HRAS—thyroid cancer	1.05e-05	0.000145	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CALCA—thyroid cancer	1.05e-05	0.000144	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HRAS—thyroid cancer	1.03e-05	0.000142	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—AKT1—thyroid cancer	1.02e-05	0.000141	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—PTEN—thyroid cancer	1.01e-05	0.000139	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TPR—thyroid cancer	9.91e-06	0.000137	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	9.91e-06	0.000136	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SST—thyroid cancer	9.87e-06	0.000136	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	9.85e-06	0.000136	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TERT—thyroid cancer	9.76e-06	0.000134	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PRKAR1A—thyroid cancer	9.75e-06	0.000134	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—SLC5A5—thyroid cancer	9.73e-06	0.000134	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—PTEN—thyroid cancer	9.72e-06	0.000134	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CALCA—thyroid cancer	9.5e-06	0.000131	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDK1—thyroid cancer	9.48e-06	0.000131	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—KRAS—thyroid cancer	9.38e-06	0.000129	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—SLC5A5—thyroid cancer	9.35e-06	0.000129	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HIF1A—thyroid cancer	9.33e-06	0.000129	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TPR—thyroid cancer	9.31e-06	0.000128	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—AKT1—thyroid cancer	9.28e-06	0.000128	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—PTEN—thyroid cancer	9.18e-06	0.000126	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	9.16e-06	0.000126	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—AKT1—thyroid cancer	9.13e-06	0.000126	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—NRAS—thyroid cancer	9.03e-06	0.000124	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—thyroid cancer	9e-06	0.000124	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CALCA—thyroid cancer	8.86e-06	0.000122	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	8.84e-06	0.000122	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—RXRA—thyroid cancer	8.83e-06	0.000122	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—PTEN—thyroid cancer	8.82e-06	0.000121	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	8.76e-06	0.000121	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—AKT1—thyroid cancer	8.74e-06	0.00012	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—NRAS—thyroid cancer	8.67e-06	0.000119	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDK1—thyroid cancer	8.6e-06	0.000118	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.59e-06	0.000118	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	8.37e-06	0.000115	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—NRAS—thyroid cancer	8.19e-06	0.000113	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—RXRA—thyroid cancer	8.18e-06	0.000113	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDK1—thyroid cancer	8.02e-06	0.00011	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—HRAS—thyroid cancer	7.97e-06	0.00011	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—NRAS—thyroid cancer	7.87e-06	0.000108	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—RXRA—thyroid cancer	7.85e-06	0.000108	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTEN—thyroid cancer	7.85e-06	0.000108	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—KRAS—thyroid cancer	7.77e-06	0.000107	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—BRAF—thyroid cancer	7.73e-06	0.000106	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—AKT1—thyroid cancer	7.64e-06	0.000105	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	7.64e-06	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NRG1—thyroid cancer	7.61e-06	0.000105	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KRAS—thyroid cancer	7.47e-06	0.000103	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SLC5A5—thyroid cancer	7.42e-06	0.000102	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—KRAS—thyroid cancer	7.05e-06	9.71e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—AKT1—thyroid cancer	7.04e-06	9.69e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	6.97e-06	9.6e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NRG1—thyroid cancer	6.9e-06	9.5e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TERT—thyroid cancer	6.83e-06	9.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KRAS—thyroid cancer	6.77e-06	9.32e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HRAS—thyroid cancer	6.61e-06	9.1e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HIF1A—thyroid cancer	6.54e-06	9e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NRG1—thyroid cancer	6.44e-06	8.87e-05	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—AKT1—thyroid cancer	6.38e-06	8.78e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HRAS—thyroid cancer	6.35e-06	8.74e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—thyroid cancer	6.24e-06	8.6e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—RXRA—thyroid cancer	6.24e-06	8.59e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TERT—thyroid cancer	6.2e-06	8.53e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	6.07e-06	8.35e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HRAS—thyroid cancer	5.99e-06	8.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HIF1A—thyroid cancer	5.93e-06	8.16e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTEN—thyroid cancer	5.9e-06	8.12e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—RXRA—thyroid cancer	5.86e-06	8.07e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—thyroid cancer	5.84e-06	8.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TERT—thyroid cancer	5.78e-06	7.96e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—thyroid cancer	5.75e-06	7.92e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—thyroid cancer	5.6e-06	7.72e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PPARG—thyroid cancer	5.58e-06	7.68e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—thyroid cancer	5.57e-06	7.67e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HIF1A—thyroid cancer	5.53e-06	7.61e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTEN—thyroid cancer	5.44e-06	7.5e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—BRAF—thyroid cancer	5.41e-06	7.45e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—thyroid cancer	5.35e-06	7.36e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—thyroid cancer	5.29e-06	7.29e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NRAS—thyroid cancer	5.26e-06	7.24e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PPARG—thyroid cancer	5.16e-06	7.11e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—thyroid cancer	5.08e-06	7e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PPARG—thyroid cancer	4.96e-06	6.83e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BRAF—thyroid cancer	4.91e-06	6.76e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NRAS—thyroid cancer	4.86e-06	6.69e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTEN—thyroid cancer	4.86e-06	6.69e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NRAS—thyroid cancer	4.77e-06	6.57e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BRAF—thyroid cancer	4.58e-06	6.3e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KRAS—thyroid cancer	4.53e-06	6.24e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—thyroid cancer	4.52e-06	6.23e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—thyroid cancer	4.39e-06	6.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KRAS—thyroid cancer	4.18e-06	5.76e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KRAS—thyroid cancer	4.11e-06	5.65e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—thyroid cancer	4.06e-06	5.59e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—thyroid cancer	3.95e-06	5.44e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PPARG—thyroid cancer	3.94e-06	5.42e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—thyroid cancer	3.9e-06	5.37e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—thyroid cancer	3.85e-06	5.3e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—thyroid cancer	3.82e-06	5.27e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—thyroid cancer	3.81e-06	5.25e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PPARG—thyroid cancer	3.7e-06	5.09e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—thyroid cancer	3.6e-06	4.96e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—thyroid cancer	3.58e-06	4.93e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—thyroid cancer	3.55e-06	4.89e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—thyroid cancer	3.54e-06	4.88e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—thyroid cancer	3.49e-06	4.81e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—thyroid cancer	3.46e-06	4.76e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—thyroid cancer	3.4e-06	4.68e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NRAS—thyroid cancer	3.4e-06	4.68e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—thyroid cancer	3.4e-06	4.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTEN—thyroid cancer	3.23e-06	4.44e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—thyroid cancer	3.14e-06	4.32e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NRAS—thyroid cancer	3.08e-06	4.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—thyroid cancer	3.08e-06	4.24e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KRAS—thyroid cancer	2.93e-06	4.03e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—thyroid cancer	2.91e-06	4.01e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NRAS—thyroid cancer	2.88e-06	3.96e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—thyroid cancer	2.8e-06	3.85e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—thyroid cancer	2.7e-06	3.72e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KRAS—thyroid cancer	2.65e-06	3.66e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—thyroid cancer	2.6e-06	3.58e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—thyroid cancer	2.54e-06	3.49e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—thyroid cancer	2.49e-06	3.43e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KRAS—thyroid cancer	2.48e-06	3.41e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—thyroid cancer	2.36e-06	3.25e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—thyroid cancer	2.26e-06	3.11e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—thyroid cancer	2.2e-06	3.03e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—thyroid cancer	2.2e-06	3.03e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—thyroid cancer	2.11e-06	2.9e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—thyroid cancer	2.04e-06	2.81e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—thyroid cancer	1.99e-06	2.74e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—thyroid cancer	1.96e-06	2.7e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—thyroid cancer	1.86e-06	2.56e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—thyroid cancer	1.56e-06	2.14e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—thyroid cancer	1.46e-06	2.01e-05	CbGpPWpGaD
